|
WO2013059648A1
|
|
2,3,5 trisubstituted aryl and heteroaryl amino derivatives, compositions, and methods of use
|
|
JP2011231094A
|
|
Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, composition and method of use
|
|
EP2389371A2
|
|
Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use
|
|
US2009258844A1
|
|
Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
|
|
JP2009102330A
|
|
Method and composition for treatment of anxiety disorder
|
|
EP1937242A2
|
|
Methods and compositions for the treatment of neuropsychiatric and addictive disorders
|
|
CA2625362A1
|
|
Methods and compositions for the treatment of neuropsychiatric and addictive disorders
|
|
CA2625918A1
|
|
Diuretic-like compound analogs useful for regulation of central nervous system disorders
|
|
US2006089350A1
|
|
Methods and compositions for the treatment of neuropsychiatric disorders
|
|
EP2332580A1
|
|
A composition for the treatment of the central nervous system
|
